Early phase clinical trial units (epctu)
Active Awarded Last action
- Contract number
- 75N93022D00016
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $3,294,071 obligated
Award facts
- Opportunity
-
- Early Phase Clinical Trial Units (EPCTU) Pre-Solicitation · 75N93020R00023 · Posted Nov 19, 2020
- Combined order value
-
- $3,294,071 Current, with exercised options
- $4,456,664 Potential, with all options
- Last date to order 48% complete
- IDV ceiling 1% used
- $346,610,277.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite-delivery, multiple-award contract to Dynport Vaccine Company LLC on January 14, 2022, with a ceiling of $346.61 million and an ultimate completion date of January 13, 2032. This vehicle carries no set-aside designation.
Place of performance is Frederick, Maryland, with work encompassing Phase 0 through Phase III clinical trials of investigational infectious disease products conducted domestically and internationally.
The EPCTU contract solicitation, posted in November 2020, sought multiple contractors to support the full range of early phase clinical trial activities, including administrative support, healthy volunteer studies (Phase 0 and Phase I), Phase I special population studies, and Phase II and III patient studies. NAICS codes 541715 and 541712 and PSC codes R425 and R499 apply. The ordering period runs seven years from award.
Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation, has executed task orders under this IDIQ employing cost-plus-fixed-fee pricing. Task Order 75N93022F00001, awarded January 21, 2022, carries a ceiling of $2.19 million with completion through January 13, 2032. A second delivery order awarded May 15, 2023, valued at $2.27 million, extends through July 15, 2025 and engages subcontractors including Kcas LLC and Altasciences Clinical Kansas Inc., which provides advanced clinical pharmacology research services.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Epctu | National Institute of Allergy and Infectious Diseases (NIH) | $2,265,501 | |
| Task order 75N93022F00001 base award | National Institute of Allergy and Infectious Diseases (NIH) | $1,028,570 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Kcas LLC | $69,372 | |
| Altasciences Clinical Kansas Inc. | $217,585 |
Quick answers
Who was awarded contract 75N93022D00016?
75N93022D00016 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 14, 2022.
How much is contract 75N93022D00016 worth?
Orders under 75N93022D00016 have obligated $3,294,071. Their combined potential value, with all options, is $4,456,664. 75N93022D00016's own ceiling is $346,610,277.
How many orders have been placed under contract 75N93022D00016?
2 orders have been placed under 75N93022D00016, the latest on May 15, 2023.
Who can order from contract 75N93022D00016?
75N93022D00016 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93022D00016 part of a contract vehicle?
Yes. 75N93022D00016 is part of Early Phase Clinical Trial Units (EPCTU).
Was contract 75N93022D00016 competed?
The extent of competition for 75N93022D00016 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV